MAUNA KEA TECH : Mauna Kea Technologies: 2012 Financial Calendar

Regulatory News:

Mauna Kea Technologies (NYSE Euronext: MKEA, FR0010609263) (Paris:MKEA), the leader in the endomicroscopy market, today announces its schedule for the publication information for 2012.

Event		Date *
2011 annual revenues		Thursday January 19, 2012
2011 annual results		Wednesday April 4, 2012
2012 First-quarter revenues		Tuesday May 15, 2012
Annual General Meeting		Friday June 15, 2012
2012 First-half revenues		Monday July 30, 2012
2012 first-half results		Thursday August 30, 2012
2012 third-quarter revenues		Tuesday November 13, 2012

* Subject to modification. Press releases are published after market closes.

About Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company and a leader in endomicroscopic innovation. The company designs, develops and markets innovative tools to visualize and help detect abnormalities in the gastrointestinal and pulmonary tracts. Its flagship product (Cellvizio®, a probe-based confocal laser endomicroscopy (pCLE) system) provides physicians and researchers with high-resolution cellular views of tissue inside the body. Large, international, multicenter clinical trials have demonstrated Cellvizio®'s ability to help physicians more accurately detect early forms of disease and make treatment decisions immediately. Designed to improve patient outcomes and reduce hospital costs, Cellvizio can be used with almost any endoscope. Cellvizio® has 510(k) clearance from the U.S. Food and Drug Administration and the European CE-Mark for use in the gastrointestinal and pulmonary tracts.

For more information on Mauna Kea Technologies, visit www.maunakeatech.com

Next press release: 2011 annual revenues - Thursday January 19, 2012

United States
Erich Sandoval
Lazar Partners Ltd.
Tel: [phone]
[e-mail]
or
Mauna Kea Technologies
Alexander Bryson
Marketing Communications and Brand Manager
Tel: [phone]
[e-mail]
or
France and Europe
ALIZE RP
Caroline Carmagnol
Tel: + 33 1 42 68 86 43 / + 33 6 64 18 99 59
[e-mail]
Anne?Sophie Cosquéric
Tel: + 33 1 42 68 86 41
[e-mail]
or
NewCap
Investor Relations and Financial Communication
Pierre Laurent / Florent Alba
Tel: [phone]
[e-mail]